Postinfectious irritable bowel syndrome after travelers' diarrhea – a cohort study

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2982|27|8|1147-1155

ISSN： 1350-1925

Source： NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol.27, Iss.8, 2015-08, pp. : 1147-1155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systematic review with meta‐analysis: post‐infectious irritable bowel syndrome after travellers' diarrhoea

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 11, 2015-06 ,pp. : 1029-1037

John Wiley & Sons Inc

Access to resources Recommend Favorite

Alosetron for severe diarrhea-predominant irritable bowel syndrome: improving patient outcomes

By Bleser Scott  

Current Medical Research and Opinion, Vol. 27, Iss. 3, 2011-03 ,pp. : 503-512

Informa Healthcare

Access to resources Recommend Favorite

Alosetron: an effective treatment for diarrhea-predominant irritable bowel syndrome

By Harris Lucinda A   Chang Lin  

Women's Health, Vol. 3, Iss. 1, 2007-01 ,pp. : 15-27

Future Medicine

Access to resources Recommend Favorite

Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 30, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pilot study of Biomarkers for predicting effectiveness of ramosetron in diarrhea‐predominant irritable bowel syndrome: expression of S100A10 and polymorphisms of TPH1

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 27, Iss. 1, 2015-01 ,pp. : 82-91

John Wiley & Sons Inc

Access to resources Recommend Favorite